Oligomerix, Inc

Oligomerix, Inc

Biotechnology Research White Plains, New York, United States 10 employees
Employees
10
Contacts
4
Emails
4
Phones
2

Oligomerix, Inc Overview

Headquarters
White Plains, New York, United States
Phone Number
Available in AeroLeads
Website
oligomerix.com
Industry
Biotechnology Research
Employees
10
Founded
2006
Funding
2.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Oligomerix, Inc

Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. With a focus on oral, small molecule, tau self-association inhibitors, Oligomerix seeks to develop therapies for Alzheimer’s disease and other dementias that are easy to administer and cost effective, and which are expected to significantly add to newly emerging high-cost therapeutic options such as the monoclonal antibody targeted against beta-amyloid that was recently approved by the U.S. FDA. Oligomerix is headquartered at the Westchester Park Center in White Plains, New York and has lab facilities at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine.

Oligomerix, Inc Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Oligomerix, Inc Org Chart

Sample employees and titles
Name Title Contact
Dhruv Patel, Ph.d. Scientist at Oligomerix Inc., Ny Usa
Email Phone
James Moe President & CEO, Head of Discovery
Email Phone
Bob Foerster Chief Financial Officer at Oligomerix
Email
Doug Durand
Email

Employees by Management Level

Executive 3 profiles
Individual contributor 1 profile

Compare Similar Companies to Oligomerix, Inc